Skip to main content
Premium Trial:

Request an Annual Quote

Transgenomic, Max-Planck Union Aims for Affordable Large-Scale Genetic-Variability Studies

NEW YORK, Feb. 7 - Transgenomic on Thursday said that it has begun a partnership with the Max-Planck Institute for Molecular Genetics to develop a high-throughput system to discover genetic variation.

 

The partners hope that their multiyear collaboration, funded by the German National Genome Research Network, will create a system that will permit large-scale studies of genetic variability at a reasonable cost.

 

The research will be conducted in the labs of Max Planck's Hans Lehrach, who heads the institute's department of vertebrate genomics. That group, which is involved in a comprehensive project to isolate and identify the genes of the vertebrate genome, now focuses on model organism genomes as well as human chromosomes X and 21, and the genetics of Huntington's chorea.

 

Transgenomic, based in Omaha, Neb., develops and sells DNA and RNA analysis instruments. Its Wave system identifies DNA mutations using micro-beads and a DNA separation column.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.